ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.26
Bid
0.24
Offer
0.26
Volume
17,500
0.24 Day's Range 0.26
0.14 52 Week Range 0.38
Market Cap
Previous Close
0.245
Open
0.245
Last Trade
1000
@
0.26
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
128,747
Shares Outstanding
228,460,000
Dividend Yield
-
PE Ratio
-13.00
Earnings Per Share (EPS)
-0.02
Revenue
1.07M
Net Profit
-4.57M

About Theralase Technologies Inc

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
Toronto, Ontario, Can
Founded
-
Theralase Technologies Inc is listed in the Electromedical Apparatus sector of the TSX Venture Exchange with ticker TLT. The last closing price for Theralase Technologies was $0.25. Over the last year, Theralase Technologies shares have traded in a share price range of $ 0.14 to $ 0.38.

Theralase Technologies currently has 228,460,000 shares in issue. The market capitalisation of Theralase Technologies is $55.97 million. Theralase Technologies has a price to earnings ratio (PE ratio) of -13.00.

TLT Latest News

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TLT.WT

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TLT.WT Canada NewsWire VANCOUVER, BC, le 22 août 2024 VANCOUVER, BC, le 22 août...

Canadian Investment Regulatory Organization Trading Halt - TLT.WT

Canadian Investment Regulatory Organization Trading Halt - TLT.WT Canada NewsWire VANCOUVER, BC, Aug. 22, 2024 VANCOUVER, BC, Aug. 22, 2024 /CNW/ - The following issues have been halted by...

24/02/13 - TSX Venture Exchange Stock Maintenance Bulletins

24/02/13 - TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Feb. 13, 2024 VANCOUVER, BC, Feb. 13, 2024 /CNW/ -TSX VENTURE COMPANIES BULLETIN V2024-0472 HIGH TIDE...

Theralase® Releases FY2022 Audited Financial Statements

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium

TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company

TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium

TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

Theralase ® Announces Warrant Extension

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...

TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Jan. 5, 2023 VANCOUVER, BC, Jan. 5, 2023 /CNW/ - TSX VENTURE COMPANIES ALPINE SUMMIT ENERGY PARTNERS, INC...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.260.280.23979620.25408537CS
4-0.02-7.142857142860.280.30.21243310.23922488CS
120.0952.94117647060.170.380.171287470.28246062CS
260.0736.84210526320.190.380.16946970.24452036CS
520.09557.57575757580.1650.380.141158130.20773487CS
156-0.075-22.38805970150.3350.480.141164260.27780651CS
260-0.07-21.21212121210.330.480.121897990.24499024CS

TLT - Frequently Asked Questions (FAQ)

What is the current Theralase Technologies share price?
The current share price of Theralase Technologies is $ 0.26
How many Theralase Technologies shares are in issue?
Theralase Technologies has 228,460,000 shares in issue
What is the market cap of Theralase Technologies?
The market capitalisation of Theralase Technologies is CAD 55.97M
What is the 1 year trading range for Theralase Technologies share price?
Theralase Technologies has traded in the range of $ 0.14 to $ 0.38 during the past year
What is the PE ratio of Theralase Technologies?
The price to earnings ratio of Theralase Technologies is -13
What is the cash to sales ratio of Theralase Technologies?
The cash to sales ratio of Theralase Technologies is 55.32
What is the reporting currency for Theralase Technologies?
Theralase Technologies reports financial results in CAD
What is the latest annual turnover for Theralase Technologies?
The latest annual turnover of Theralase Technologies is CAD 1.07M
What is the latest annual profit for Theralase Technologies?
The latest annual profit of Theralase Technologies is CAD -4.57M
What is the registered address of Theralase Technologies?
The registered address for Theralase Technologies is 41 HOLLINGER ROAD, TORONTO, ONTARIO, M4B 3G4
What is the Theralase Technologies website address?
The website address for Theralase Technologies is www.theralase.com
Which industry sector does Theralase Technologies operate in?
Theralase Technologies operates in the ELECTROMEDICAL APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CANSWildpack Beverage Inc
$ 0.01
(100.00%)
2.12M
SQGSpackman Equities Group Inc
$ 4.26
(70.40%)
48.12k
PWROPower One Resources Corp
$ 0.025
(66.67%)
31k
NZPChatham Rock Phosphate Limited
$ 0.08
(60.00%)
2.2k
ADDArctic Star Exploration Corp
$ 0.015
(50.00%)
2k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
2k
CCDCascadero Copper Corporation
$ 0.005
(-50.00%)
1.56k
KGL.HKGL Resources Ltd
$ 0.03
(-40.00%)
5.5k
SAFSeasif Exploration Inc
$ 0.025
(-37.50%)
61k
AAZAzincourt Energy Corp
$ 0.01
(-33.33%)
110.54k
CPLCopper Lake Resources Ltd
$ 0.01
(0.00%)
11.98M
WCUWorld Copper Ltd
$ 0.05
(-23.08%)
5.75M
QNCQuantum Emotion Corp
$ 0.66
(24.53%)
4.89M
THRMTherma Bright Inc
$ 0.035
(16.67%)
2.64M
CANSWildpack Beverage Inc
$ 0.01
(100.00%)
2.12M

TLT Discussion

View Posts
Dead On Arrival Dead On Arrival 7 days ago
I think we see something big by end of next month. Cannot believe the potential of this company yet the price is stagnant. Not a fan of the CEO and that might be hurting us.
👍️0
Dead On Arrival Dead On Arrival 4 months ago
They have had large placements that have been horrible to investors. Roger seems to have zero traction with obtaining funding and that could be the result of terrible relationships with tutes and past investors. I have no idea why he has come back to the helm. Not a wise choice but nothing you can do about it. They have no IR at present as the current one is a BOD member and personal friend of Roger. Obviously works cheap. Roger's wife is second in command at the company so it is all kept in house.Some of usshareholders are concerned they are going to run out of capital because they can only raise in paltry amounts and that is going to dry up.

Great product but is hindered by management that cannot raise money. At present they are still trying to tap a large investor(public news) to take down a chunk but still no bite. I have no idea what will move the stock anymore. Every bit of news put out is meant by manipulative selling on the Venture Exchange. I really like the inventor of the drug. She is a wonderful lady.
👍️0
trader_ron trader_ron 4 months ago
TLTFF needs coverage, News, something to entice investors, way to quiet
👍️0
trader_ron trader_ron 5 months ago
Caveat Emptor, nice news but the management is outta its league.
👍️0
Dead On Arrival Dead On Arrival 7 months ago
Great PR today from Canada. Wish the stock had more volume but the potential for a big move is there. We just have to get rid of the management team and bring in someone capable of raising funds. The stock price is very cheap.
👍️0
-3 -3 1 year ago
Had warrants that expired Aug 2024 sold them . Bought shares of BIG.v . Big has found a very large ore deposit in Idaho . Profound science at TLT . Big pharma is corrupt .

Big should show $10 in 24 and multiples in 05 as they show how valuable it is .
👍️0
Seasighs Seasighs 1 year ago
“Cure for Cancer?”
Sounds good to Me.
👍️ 1
-3 -3 2 years ago
Chart reader says a technical buy to .39 . We are so close to a boil over . Good luck !

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35384358
👍️ 1
-3 -3 2 years ago
Chart reader says a technical buy to .39 . We are so close to a boil over . Good luck !
👍️0
-3 -3 2 years ago
Some wording in patent gets us a temporary rejection . How the rest of it will roll out is beyond me at this time .
👍️0
-3 -3 2 years ago
This is well said . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35321535
👍️0
-3 -3 2 years ago
This is a treatment that kills cancer at the cellular level . If the first or 7th treatment doesn't get what is left , treat them again . No side effects ????
👍️0
-3 -3 2 years ago
That 89% is for efficacy .
👍️0
-3 -3 2 years ago
If we take out the wrong dose patients this poster says 89% .

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35291142
👍️0
-3 -3 2 years ago
Post by Guzzi , TLT.v looks like the big time .

https://fortworthreport.org/2022/03/14/listen-this-ut-arlington-researcher-is-treating-cancer-with-light/
👍️0
MeghanStar MeghanStar 2 years ago
Thanks.. maybe the stock will pop..

after the next announcing of clinical results.. FEB 16-18 San Fran..

https://finance.yahoo.com/news/theralase-phase-ii-nmibc-clinical-120000686.html
👍️0
-3 -3 2 years ago
Nice !
👍️0
MeghanStar MeghanStar 2 years ago
So far so good.. Theralase

In my thoughts as a small time stock watcher without any real insights into a company ..all I can really do is watch for sentiment in a stock chart then make some guesses.

Here is my latest guess on Theralase

👍️0
MeghanStar MeghanStar 2 years ago
Downward trend line broken = anticipation?

I don't know but I do see sustained volume along with the trend.. and the Warrant extension (again) has me thinking that Theralase wants long term warrant holders to get paid. Seems logical and fair since timelines are difficult to predict when it comes to live human testing.

I am taking all of this as a positive in advance of.. wait for it....news. Just like every other stock I dabble in.
👍️0
-3 -3 2 years ago
Good summary of what TLTFF has . https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=35183957
👍️ 1
-3 -3 2 years ago
Insiders have loaded up . Time for news to show why and price to be proof .
👍️0
-3 -3 2 years ago
https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=35015853

Great post from Stockhouse .
👍️0
MeghanStar MeghanStar 2 years ago
2 Separate Equity Offering in 2 weeks?

Oct 3 2022: https://finance.yahoo.com/news/theralase-commences-2-5-m-110000381.html

Sep 29 2022 https://finance.yahoo.com/news/theralase-announces-warrant-extension-210100300.html

Sep 22 2022: https://finance.yahoo.com/news/theralase-closes-2-5m-private-215500303.html

All of this action looks to set 2023 as the year for Theralase
👍️0
MeghanStar MeghanStar 2 years ago
Good timing for Theralase re:Biden

I like the moonshot analogy.. are we closer to the moon than we appear?

👍️0
MeghanStar MeghanStar 2 years ago
Someone thinks Theralace arrived.

Truth be told I don't have any facts except noting that the volume moving up over the last month has buoyed my spirit.

If cheap share were to be had they are going fast...er
👍️0
-3 -3 2 years ago
This poster thinks we are almost at the point of proof .

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34954321
👍️0
-3 -3 2 years ago
This stockhouse poster has a + view and the #s on TLT.

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34940829
👍️0
-3 -3 2 years ago
Looks a bit like TLT ?????????? https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34939963

The downside risk is very low . The upside could be high
👍️0
MeghanStar MeghanStar 2 years ago
Quarterly Update..

Seemes like positive growth despite
losing money.. that's expected.. isn't it?
👍️0
-3 -3 2 years ago
Anyone read " Jessie Stine's " book ?
👍️0
-3 -3 2 years ago
Egon. post at 4126 answers those ? of a long term investment .

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168672114
👍️0
-3 -3 2 years ago
The board needs the opinion of a knowing trader . How can you place a value on this if it kills all cancers . How will it play out if it does .

Most likely play if it doesn't . How can you get a fair price for it ?
👍️0
-3 -3 2 years ago
94.4 % kill of cancer out of 38 treated . Have to keep the mess ups in the data to keep the confusion . This poster figures it out .


https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34794725
👍️0
SPORT19 SPORT19 3 years ago
Looking good

Thanks BigK

👍️0
-3 -3 3 years ago
Informed poster https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34750757
👍️0
BIGKAHUNA57 BIGKAHUNA57 3 years ago
Total Evaluable Patients - Great Updates

Total Patient population and Total Optimized Patient population

https://postimg.cc/mPLRXpp4

Updated from April 5 to April 29:

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34650518

All references in this post from Stockhouse and their respective authors/members.

Good luck to all. Regards,BK
👍️0
-3 -3 3 years ago
To have a Complete Response 53 % . 24 % we will know in a few days . Potential 77 % . Beyond to 90's is still open .

Nearest competitor 28 % .At some point going to get rough on the other guys .
👍️0
-3 -3 3 years ago
We are close to a breakaway . If your science is sound buy them when they go on sale .
👍️0
-3 -3 3 years ago
Eogan. tells us what TLT has achieved and what they further expect to do .

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34633988
👍️0
-3 -3 3 years ago
Warrants will not be paid move ? Warrants due end of month ?
👍️0
-3 -3 3 years ago
Might be the simplest/clearest understanding of the treatment mess . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34627578
👍️0
-3 -3 3 years ago
This is an interpretation of data that is helpful . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34612170
👍️0
-3 -3 3 years ago
Is this the explanation ? https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34606918
👍️0
-3 -3 3 years ago
Here is a criticism that to me is valid . Perhaps not buying until over $ 1 is the wise choice . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34606739
👍️0
123414 123414 3 years ago
$TLTFF - receives a target raise from Research Capital

Published on April 5, 2022

New interim clinical data has Research Capital Corporation analyst Andr Uddin feeling more bullish about Canadian drug developer Theralase Technologies (Theralase Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:TLT). Uddin maintained a “Speculative Buy” rating while raising his target price from $0.70/share to $1.20/share for a projected return of 161 per cent in an update to clients on Tuesday.

Theralase Technologies receives a target raise from Research Capital (cantechletter.com/)
👍️0
-3 -3 3 years ago
Thnks !
👍️0
123414 123414 3 years ago
Theralase Technologies receives a target raise from Research-Capital

123414 Still long TLTFF.

The 67% CR@ 18/24 months is unmatched.

Those full dose patients are becoming dominate in the study.

Under-treaded patients are still in the mix but getting reduced.
AND... Now the kicker... the undertreated patients were not treated in the protocol of the study.

Read what the analysis says about all the one dose patients.

TLTFF on track and still solid as heck.

That's why that analyists moved his rating to .95usd / 1.20cad

He nailed it before.

Stay tuned sports fan the race is just heating up.

Theralase Technologies receives a target raise from Research-Capital

https://www.cantechletter.com/2022/04/theralase-technologies-receives-a-target-raise-from-research-capital/
👍️0
-3 -3 3 years ago
123414 Take it you bailed ? The science is to fall in love with , the execution is to bring tears .
👍️0
-3 -3 3 years ago
Buy today results are great . https://www.siliconinvestor.com/readmsg.aspx?msgid=33789452
👍️0
123414 123414 3 years ago
The full Doses are now becoming dominant in the study.
The first ph2 12 patients who were under treated in the first dose negativly affected the CR rates.

Now the full dose patients are starting to show up at the data points.

It's gonna be good.
👍️0

Your Recent History

Delayed Upgrade Clock